க்யாத்லீந் பைஸ்லி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from க்யாத்லீந் பைஸ்லி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In க்யாத்லீந் பைஸ்லி Today - Breaking & Trending Today

Investegate |Oxurion NV Announcements | Oxurion NV: Oxurion NV Business and Financial Update – FY 2020


 
First patients dosed in Phase 2 study (‘KALAHARI’) evaluating multiple injections of THR-149, a potent plasma kallikrein inhibitor, for the treatment of DME. Part A data expected by mid-year
 
THR-687, a pan-RGD integrin antagonist, Phase 2 DME study planned to start by mid-year, following positive Phase 1 data released in 2020
 
The Company has strengthened the management team with the appointments of Tom Graney, CFA, based in Boston as CFO, Grace Chang M.D., PhD, based in LA as CMO, and Professor Alan Stitt, PhD as CSO.
 
At the end of December 2020, Oxurion had cash, cash equivalents & investments of €24.8 million, allowing the Company to execute on its business plans through the end of Q3 2021.  The Company is in advanced discussions with potential investors in order to increase its cash position. ....

United States , Bruxelles Capitale , New York , France General , Region Flamande , Tom Graney , City Of , United Kingdom , Jean Feyen , Ramin Tadayoni , Grace Chang , Dominique Vanfleteren , Arshad Khanani , Sylvie Berrebi Frazer Hall , Los Angeles , Wouter Piepers , Jo Van Ginderachter , Claude Sander , Kathleen Paisley , Citigate Dewe Rogerson , Christopher Brinzey , Yale Law School , Ironwood Pharmaceuticals , Bascom Palmer Eye Institute Angiogenesis , Queen Mary University Of London , University Of Nevada ,

Oxurion NV Business and Financial Update – FY 2020


 
First patients dosed in Phase 2 study (‘KALAHARI’) evaluating multiple injections of THR-149, a potent plasma kallikrein inhibitor, for the treatment of DME. Part A data expected by mid-year
 
THR-687, a pan-RGD integrin antagonist, Phase 2 DME study planned to start by mid-year, following positive Phase 1 data released in 2020
 
The Company has strengthened the management team with the appointments of Tom Graney, CFA, based in Boston as CFO, Grace Chang M.D., PhD, based in LA as CMO, and Professor Alan Stitt, PhD as CSO.
 
At the end of December 2020, Oxurion had cash, cash equivalents & investments of €24.8 million, allowing the Company to execute on its business plans through the end of Q3 2021.  The Company is in advanced discussions with potential investors in order to increase its cash position. ....

United States , Bruxelles Capitale , New York , France General , Region Flamande , Tom Graney , City Of , United Kingdom , Jean Feyen , Ramin Tadayoni , Grace Chang , Dominique Vanfleteren , Arshad Khanani , Sylvie Berrebi Frazer Hall , Los Angeles , Wouter Piepers , Jo Van Ginderachter , Claude Sander , Kathleen Paisley , Citigate Dewe Rogerson , Christopher Brinzey , Yale Law School , Ironwood Pharmaceuticals , Bascom Palmer Eye Institute Angiogenesis , Queen Mary University Of London , University Of Nevada ,

Disclosure Issues in International IP Arbitration


Introduction
When parties choose arbitration to resolve their IP disputes, there are certitudes to guide them on arbitration law and procedure, and how their case will be handled: the courts will help enforce their arbitration clause; an impartial tribunal will be selected to judge the case without a jury; and the final award will be widely enforceable in the signatory nations of the New York Convention.
[2] But the details of what the particular procedure will be like are often not well known in advance, and in no area are these uncertainties greater than in the procedure the tribunal will adopt for the most important phase of fact-finding in IP and other disputes: disclosure and discovery – that is, the exchange among the parties of relevant documentary and testimonial evidence that can be used to build, or confirm, the legal arguments in the case. ....

New York , United States , France General , United Kingdom , Hanwei Guo , Azko Nobel , Kathleen Paisley , Us Department Of Commerce , European Company Lawyers Association , Akzo Nobel Chemicals Ltd , Akcros Chemicals Ltd , European Union , York Convention , European Court , French Supreme Court , Association Of Corporate Counsel , Competition Of The European Commission , European Commission , Supreme Court , Council Of Bars , Us Supreme Court , International Arbitration , International Bar Association , New York Convention , Data Protection Regulation , Dutch Bar ,